RadNet, Inc.
RDNT
Peringkat dalam Saham
#3240
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Harga Saham
$69.56
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$5.47B
Perubahan (1 hari)
1.10%
Perubahan (1 tahun)
-11.33%
Negara
US
Perdagangan RadNet, Inc. (RDNT)
Kategori
Healthcare
Laba untuk RadNet, Inc. (RDNT)
Laba pada Jun 2026 TTM: $34.98M
Menurut laporan keuangan terbaru dari RadNet, Inc., laba saat ini perusahaan adalah $34.98M. Pada tahun 2023, perusahaan memperoleh laba sebesar $38.81M, penurunan dibandingkan dengan laba tahun 2022 sebesar $42.97M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk RadNet, Inc. dari 2000 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $34.98M | -22.03% |
| 2024 | $44.86M | 15.59% |
| 2023 | $38.81M | -9.68% |
| 2022 | $42.97M | -27.02% |
| 2021 | $58.88M | -6,994.50% |
| 2020 | $-854.00K | -102.88% |
| 2019 | $29.67M | -22.99% |
| 2018 | $38.53M | 46.02% |
| 2017 | $26.39M | 112.17% |
| 2016 | $12.44M | -15.08% |
| 2015 | $14.65M | 301.01% |
| 2014 | $3.65M | -37.95% |
| 2013 | $5.89M | -380.42% |
| 2012 | $-2.10M | -171.44% |
| 2011 | $2.94M | -114.45% |
| 2010 | $-20.34M | 99.64% |
| 2009 | $-10.19M | -46.58% |
| 2008 | $-19.07M | 5.18% |
| 2007 | $-18.13M | 163.00% |
| 2006 | $-6.89M | 119.90% |
| 2005 | $-3.14M | -66.44% |
| 2004 | $-9.34M | 74.17% |
| 2003 | $-5.36M | 3.83% |
| 2002 | $-5.17M | -156.26% |
| 2001 | $9.18M | -36.69% |
| 2000 | $14.50M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $7.61B | 21,653.05% |
US
|
|
| $4.76B | 13,513.88% |
US
|
|
| $-252.70M | -822.44% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 4,639.99% |
US
|
